Search for Novartis AG and
    1. Fast FT

      August 17, 2016

      Norway sovereign wealth fund returns 1.3% profit

      Norway’s $890bn oil fund eked out a small positive return in the second quarter, overcoming the market turmoil...

    2. August 11, 2016

      Novartis faces potential South Korea sales ban

      Novartis has come under fresh pressure in South Korea, facing the potential suspension of some of its popular...

    Special Reports

    1. Combating Cancer

      We consider the latest in cell therapy and efforts to arm the immune system in the fig...
    2. Combating Malaria

      Malaria kills more than 400,000 people a year, most of them children in Africa. New we...
    Search more Special Reports on this topic.

    1. July 24, 2016

      Gene therapy: A controversial cure

      It sounds like something out of a science fiction novel. The body re-engineered to recognise and attack cancer, so that...

    2. July 24, 2016

      Bloodlines: Rivals look to create ‘off-the-shelf’ treatment

      Most of the companies pursuing Car-T therapies are developing products that modify cells taken from the patient’s own...

    3. July 19, 2016

      Coca-Cola HBC up on potential to buy African bottling company

      Coca-Cola HBC hit a seven-month high on Tuesday after its joint house broker flagged up the potential for major...

    4. July 19, 2016

      Novartis braced for US price shake-up after presidential election

      Novartis, the Swiss pharmaceuticals group, has said it is preparing for a tougher US price environment after the...

    5. July 14, 2016

      Biosimilars set to compete with two of world’s biggest drug franchises

      The world’s top grossing drug, Humira, generated $14bn in global sales last year for AbbVie, the Chicago-based...

    6. Fast FT

      June 14, 2016

      GSK's head of vaccines to depart next year

      The head of vaccines at GlaxoSmithKline, Moncef Slaoui, has told the UK drugmaker that he intends to step down in June...

    7. June 2, 2016

      Cancer therapy re-engineers cells to hunt and destroy

      Patients taking part in early clinical trials of the riskiest new cancer drugs are often in the final stages of the...

    8. June 1, 2016

      Novartis boss says China will continue to outstrip Europe and US

      Pharmaceutical sales growth in China will continue to outstrip Europe and the US despite the economic slowdown on the...

    9. Fast FT

      May 23, 2016

      European equities rebound led by banks

      European equities started the day with a sharp drop into the red, but have rallied since then, hauling themselves back...

    10. Fast FT

      May 17, 2016

      Epstein out as Novartis splits cancer from pharma unit

      Swiss pharmaceuticals group Novartis announced on Tuesday plans to separate its oncology unit from its pharmaceuticals...

    11. Fast FT

      April 28, 2016

      Norway's sovereign wealth fund hit by global stock turmoil

      Norway’s $870bn oil fund recorded its third quarter of negative returns in the past year as weak stock markets from...

    12. Fast FT

      April 27, 2016

      GlaxoSmithKline Q1 growth aided by HIV drugs

      Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger-than-expected rise in first quarter...

    13. April 24, 2016

      Big Pharma hunts for malaria drugs to fight mosquito resistance

      China’s first Nobel Prize for physiology or medicine was 419 years in the making. Tu Youyou, an 85 year-old chemist,...

    14. April 21, 2016

      Novartis chief warns of paradigm shift to slower US drug sales

      Pharmaceuticals companies can no longer count on rapid uptake of new drugs in the US, the chief executive of Novartis...

    15. Fast FT

      April 21, 2016

      Novartis profits drop in Q1

      Falling sales and slow sales of a vaunted new heart drug – it was much the same story for Novartis in the first months...

    16. Fast FT

      April 21, 2016

      Fast Europe Open: Turkish tensions

      Tensions are growing over a promise to grant visa-free travel for 80m Turks to Europe’s Schengen area. A month-old...

    17. April 18, 2016

      Clouds gather over Novartis as it battles series of setbacks

      Joe Jimenez is facing a battle to restore investor confidence in Novartis after a series of setbacks which have sent...

    18. April 3, 2016

      GSK returns to battle against cancer

      When GlaxoSmithKline agreed to sell its oncology drugs to Novartis for $16bn in 2014, it looked like the UK...

    19. Fast FT

      March 10, 2016

      Sanofi plucks new chief medical officer from Novartis

      French drugmaker Sanofi has plucked a new senior executive from rival Swiss healthcare group Novartis. Dr Ameet...

    20. Fast FT

      March 2, 2016

      ISS raises dividend 51%

      ISS, the Danish cleaning and catering group, more than doubled profits last year allowing it to significantly raise its...

    21. February 23, 2016

      Health spending cannot be set by fans of Facebook and Instagram

      To have the option of saving a child’s life and to reject it seems more than callous. It is the ugliest of affronts to...

    22. February 4, 2016

      Activist investors: hard drugs

      Failed in New Jersey? Try Basel. Investors in Johnson & Johnson have tried to gin up interest among activists in...

    23. February 3, 2016

      GSK’s Witty avoids the City’s would-be surgeons

      Sir Andrew Witty, chief executive of GlaxoSmithKline, is having his yearly City health check up. Corporate doctor: What...

    24. February 1, 2016

      Investor calls for big pharma to slim down grow louder

      Some of the world’s biggest pharmaceuticals groups are facing calls to break up their diversified businesses in favour...

    25. January 27, 2016

      Novartis revamps Alcon eyecare division

      Novartis has set a deadline for its struggling eyecare business to return to growth by the end of this year or risk...

    26. Fast FT

      January 27, 2016

      Novartis to streamline operations, misses estimates

      Novartis has announced plans to streamline its operations as a strong US dollar continued to weigh on its earnings. The...

    27. January 21, 2016

      Drugmakers call for collective action on superbugs

      Most of the world’s biggest pharmaceuticals groups have backed a declaration committing the industry to help tackle...

    28. January 20, 2016

      GlaxoSmithKline and Qualcomm in talks over health tech tie-up

      GlaxoSmithKline and Qualcomm are in talks to set up a joint venture potentially worth up to $1bn to develop medical...

    29. January 11, 2016

      Investors warm to UK science parks

      The UK’s largest portfolio of privately owned science parks has been bought by a US private equity company in a deal...

    30. January 3, 2016

      GSK and AstraZeneca prescribe different treatments

      For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical...

    31. December 15, 2015

      Sanofi/Boehringer: swap shop

      Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

    32. December 15, 2015

      Sanofi seeks to expand in consumer health with €18bn asset swap

      Sanofi has entered exclusive talks with Boehringer Ingelheim over an €18bn asset exchange that would see the French...

    33. December 15, 2015

      FDA performs U-turn over restriction of pain drug

      US regulators have taken the rare step of reversing a decision aimed at curbing the use of a pain medicine after the...

    34. December 7, 2015

      Race to control costs of cancer therapy revolution

      It is three and a half years since Emily Whitehead from Pennsylvania was given an experimental treatment for her acute...

    35. December 6, 2015

      China healthcare: Missing a beat

      Not long after taking the helm of GlaxoSmithKline in 2008, Sir Andrew Witty visited Shanghai to deliver a message along...

    36. November 26, 2015

      Unhealthy drugs: Pharma struggles with its reputation

      An industry dedicated to saving and extending lives might be expected to find empathy easy. Instead, some of the...

    37. November 17, 2015

      GSK and the perils of prudence

      Since the low point of the financial crisis almost seven years ago, stock markets have sent a clear message: do not...

    38. November 13, 2015

      Animal health: double or quits

      Sea lice. Fowl pox. Swine fever. Foot-and-mouth. Animal diseases often take prosaic names. This does not make them...

    Search for Novartis AG and


    Videos from that closely match this topic

    1. Novartis CEO on new growth opportunities...
      July 26, 2015

      Novartis CEO on new growth opportunities

    2. Lex on potential conflict at Swiss drugs group...
      July 17, 2013

      Lex on potential conflict at Swiss drugs group

    3. Lex on Novartis' payment to its outgoing chairman...
      February 18, 2013

      Lex on Novartis' payment to its outgoing chairman